Similar articles for PMID: 20687619

Year	Number of Results
2003	2
2004	1
2005	2
2006	2
2008	4
2009	6
2010	11
2011	6
2012	7
2013	8
2014	5
2015	9
2016	5
2017	14
2018	20
2019	11
2020	2
2021	5
2022	2
2023	1
2024	0

1

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Curran MP, Leroux-Roels I. Curran MP, et al. Drugs. 2010 Aug 20;70(12):1519-43. doi: 10.2165/11205020-000000000-00000. Drugs. 2010. PMID: 20687619 Review.

2

Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.

El Sahly HM, Keitel WA. El Sahly HM, et al. Expert Rev Vaccines. 2008 Aug;7(6):713-9. doi: 10.1586/14760584.7.6.713. Expert Rev Vaccines. 2008. PMID: 18665769 Review.

3

Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.

Vinnemeier CD, Fischer-Herr J, Meyer S, Liebig K, Theeß W, Burchard GD, Cramer JP. Vinnemeier CD, et al. Hum Vaccin Immunother. 2014;10(2):441-8. doi: 10.4161/hv.27140. Epub 2013 Nov 15. Hum Vaccin Immunother. 2014. PMID: 24240428 Free PMC article. Clinical Trial.

4

A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study.

Roggelin L, Vinnemeier CD, Meyer S, Witte K, Marx L, Theeß W, Burchard GD, Rolling T, Cramer JP. Roggelin L, et al. Hum Vaccin Immunother. 2015;11(10):2370-5. doi: 10.1080/21645515.2015.1064570. Hum Vaccin Immunother. 2015. PMID: 26114800 Free PMC article.

5

Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B.

McKeage K. McKeage K. Drugs. 2013 Sep;73(14):1587-94. doi: 10.1007/s40265-013-0114-3. Drugs. 2013. PMID: 24022123 Review.

6

A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial.

Vajo Z, Tamas F, Jankovics I. Vajo Z, et al. Clin Vaccine Immunol. 2012 Mar;19(3):313-8. doi: 10.1128/CVI.05619-11. Epub 2012 Jan 4. Clin Vaccine Immunol. 2012. PMID: 22219315 Free PMC article. Clinical Trial.

7

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects.

Choi WS, Noh JY, Song JY, Cheong HJ, Wie SH, Lee JS, Lee J, Kim SW, Jeong HW, Jung SI, Kim YS, Woo HJ, Kim KH, Kim H, Kim WJ. Choi WS, et al. Hum Vaccin Immunother. 2017 Jul 3;13(7):1653-1660. doi: 10.1080/21645515.2017.1297351. Epub 2017 Apr 13. Hum Vaccin Immunother. 2017. PMID: 28406746 Free PMC article. Clinical Trial.

8

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial.

Sharma S, Singh VB, Kumar S, Prajapati V, Patel J, Vukkala R, Jangid SK, Sanmukhani J, Gupta G, Patel P, Mittal R, Glueck R. Sharma S, et al. Hum Vaccin Immunother. 2018 Jun 3;14(6):1362-1369. doi: 10.1080/21645515.2018.1441654. Epub 2018 Mar 21. Hum Vaccin Immunother. 2018. PMID: 29461913 Free PMC article. Clinical Trial.

9

Safety, immunogenicity and cross-reactivity of a Northern hemisphere 2013-2014 seasonal trivalent inactivated split influenza virus vaccine, Anflu®.

Shen Y, Hu Y, Meng F, Du W, Li W, Song Y, Ji X, Huo L, Fu Z, Yin W. Shen Y, et al. Hum Vaccin Immunother. 2016 May 3;12(5):1229-34. doi: 10.1080/21645515.2015.1123357. Epub 2016 Mar 2. Hum Vaccin Immunother. 2016. PMID: 26934750 Free PMC article. Clinical Trial.

10

A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam.

Lan PT, Toan NT, Thang HA, Thang TC, Be LV, Thai DH, Huong VM, Nga NT, Tang Y, Holt R, Francesco BS, Flores J, Tewari T. Lan PT, et al. Hum Vaccin Immunother. 2019;15(12):2933-2939. doi: 10.1080/21645515.2019.1613127. Epub 2019 Jun 20. Hum Vaccin Immunother. 2019. PMID: 31070986 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year